Michael J. Farrell

Chief Executive Officer

Michael J. Farrell (Chief Executive Officer) filed 12 Form 4 reports in the trailing twelve months (0 purchases, 12 sales), most often in ResMed Inc. (RMD). The largest single filing was $2.3M of RMD (8,009 sh × $282.85, as filed), executed Oct 7 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 12 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$15.7M

shares × price, as filed

Last traded

Sep 8

Filed Sep 10

Median ADV $323.7M across their filed names

Open performance→

Volume by month

Buys $0 Sells $39.2M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 12 filings

Sector per market data · by filing · past 12 months

Most traded names

RMD

ResMed Inc. RMD · 0 buys · 23 sells 23 filings

Recent filings

RMDSALE ResMed Inc. View filing → $1.9M
8,009 sh × $243.23
Exec May 7 2025
Filed May 9 2025 · 5:30 PM ET RMDSALE ResMed Inc. View filing → $1.7M
8,009 sh × $209.85
Exec Apr 7 2025
Filed Apr 9 2025 · 5:30 PM ET RMDSALE ResMed Inc. View filing → $1.8M
8,009 sh × $229.20
Exec Mar 7 2025
Filed Mar 11 2025 · 5:30 PM ET RMDSALE ResMed Inc. View filing → $1.9M
8,009 sh × $236.77
Exec Feb 7 2025
Filed Feb 11 2025 · 5:30 PM ET RMDSALE ResMed Inc. View filing → $499K
2,000 sh × $249.67
Exec Nov 27 2024
Filed Nov 27 2024 · 5:30 PM ET RMDSALE ResMed Inc. View filing → $3.6M
14,683 sh × $246.26
Exec Nov 7 2024
Filed Nov 12 2024 · 5:30 PM ET RMDSALE ResMed Inc. View filing → $3.4M
14,683 sh × $231.91
Exec Oct 7 2024
Filed Oct 9 2024 · 5:30 PM ET RMDSALE ResMed Inc. View filing → $3.6M
14,683 sh × $248.38
Exec Sep 9 2024
Filed Sep 10 2024 · 5:30 PM ET